Novel Drugs in a Pipeline for Progressive Multiple Sclerosis

Multiple sclerosis (MS) is a widely known inflammatory, demyelinating disease of the central nervous system. The pathogenesis of progressive multiple sclerosis (PMS) is a complex, multi-level process that causes therapeutic difficulties. Along with variables such as age and duration of the disease,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapko, Klaudia, Jamroz-Wiśniewska, Anna, Rejdak, Konrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225445/
https://www.ncbi.nlm.nih.gov/pubmed/35743410
http://dx.doi.org/10.3390/jcm11123342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225445/
https://www.ncbi.nlm.nih.gov/pubmed/35743410
http://dx.doi.org/10.3390/jcm11123342

Ejemplares similares